NEA Management Company, LLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 53 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
NEA Management Company, LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$14,346,000
-29.0%
16,302,5960.0%0.74%
+26.2%
Q1 2022$20,215,000
-36.4%
16,302,5960.0%0.58%
-9.0%
Q4 2021$31,790,000
-28.8%
16,302,5960.0%0.64%
+20.9%
Q3 2021$44,669,000
-13.0%
16,302,5960.0%0.53%
-20.6%
Q2 2021$51,353,000
+47.9%
16,302,5960.0%0.67%
-14.1%
Q1 2021$34,725,000
+91.2%
16,302,596
+74.2%
0.78%
+62.6%
Q4 2020$18,158,0009,360,0000.48%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders